Literature DB >> 23287077

Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis.

William K K Wu1, Xiao J Wang, Alfred S L Cheng, Millore X M Luo, Simon S M Ng, Ka F To, Francis K L Chan, Chi H Cho, Joseph J Y Sung, Jun Yu.   

Abstract

Multiple intracellular signaling pathways, such as Wnt/β-catenin signaling, epidermal growth factor receptor/Ras signaling, and p53 signaling are frequently dysregulated in colorectal cancer. Recent evidence also points to the involvement of signaling pathways in the developmental process, including Notch signaling, Hedgehog signaling, and Hippo signaling. Dysregulation of these signaling pathways contribute to the acquisition of malignant phenotypes, including unchecked cell cycle progression, evasion of apoptosis, induction of genetic instability, and enhanced invasiveness and metastasis. Understanding their relative importance and crosstalk will provide a rational basis for anticancer drug development.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23287077     DOI: 10.1016/j.critrevonc.2012.11.009

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  43 in total

1.  Targeting Notch Signaling in Colorectal Cancer.

Authors:  Suman Suman; Trinath P Das; Murali K Ankem; Chendil Damodaran
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

Review 2.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 3.  Microbiota impact on the epigenetic regulation of colorectal cancer.

Authors:  Tao Yang; Jennifer L Owen; Yaíma L Lightfoot; Michael P Kladde; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2013-09-16       Impact factor: 11.951

Review 4.  A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.

Authors:  Yuhao Wang; Benjamin Bonavida
Journal:  Crit Rev Oncog       Date:  2018

5.  Wip1 abrogation decreases intestinal tumor frequency in APC(Min/+) mice irrespective of radiation quality.

Authors:  Shubhankar Suman; Bo-Hyun Moon; Hemang Thakor; Albert J Fornace; Kamal Datta
Journal:  Radiat Res       Date:  2014-08-12       Impact factor: 2.841

6.  TGFBR1*6A is a potential modifier of migration and invasion in colorectal cancer cells.

Authors:  Rui Zhou; Ying Huang; Boran Cheng; Yulei Wang; Bin Xiong
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

7.  Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation.

Authors:  Piotr M Wierzbicki; Krystian Adrych; Dorota Kartanowicz; Marcin Stanislawowski; Anna Kowalczyk; Janusz Godlewski; Iwona Skwierz-Bogdanska; Krzysztof Celinski; Tomasz Gach; Jan Kulig; Bartlomiej Korybalski; Zbigniew Kmiec
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

8.  AdipoRon: a possible drug for colorectal cancer prevention?

Authors:  Sara Malih; Rezvan Najafi
Journal:  Tumour Biol       Date:  2015-08-18

9.  NOTUM Is Involved in the Progression of Colorectal Cancer.

Authors:  Jong Hyuk Yoon; Dayea Kim; Jaeyoon Kim; Hyeongjoo Lee; Jaewang Ghim; Byung Jun Kang; Parkyong Song; Pann-Ghill Suh; Sung Ho Ryu; Taehoon G Lee
Journal:  Cancer Genomics Proteomics       Date:  2018 Nov-Dec       Impact factor: 4.069

10.  Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.

Authors:  Anita Vasudevan; Yingjie Yu; Sanjeev Banerjee; James Woods; Lulu Farhana; Sindhu G Rajendra; Aamil Patel; Gregory Dyson; Edi Levi; Krishna Rao Maddipati; Adhip P N Majumdar; Pratima Nangia-Makker
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.